Reading Room

Rewind Therapeutics to lead €2.9 million R&D collaboration to discover and develop novel drug candidates for myelin-related neurological diseases

New industry-academic collaboration leverages key areas of expertise in Flanders and is funded by the Flanders Innovation and Entrepreneurship (VLAIO) agency.